|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D34 |
Benign neoplasm of thyroid gland
|
D34 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.19%
|
20.59%
|
7.34%
|
4.04%
|
2.80%
|
1.97%
|
1.39%
|
0.86%
|
0.68%
|
0.53%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D34*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88173
|
CYTOPATH EVAL FNA REPORT |
1,847
|
2,267
|
|
10005
|
FNA BX W/US GDN 1ST LES |
1,682
|
1,682
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,656
|
5,016
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,594
|
3,118
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,477
|
6,859
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,465
|
1,482
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,447
|
1,564
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,424
|
50,647
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,230
|
10,021
|
|
76536
|
US EXAM OF HEAD AND NECK |
1,075
|
1,076
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,023
|
1,347
|
|
60220
|
PARTIAL REMOVAL OF THYROID |
1,000
|
1,000
|
|
84443
|
ASSAY THYROID STIM HORMONE |
953
|
955
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
927
|
2,918
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
888
|
3,611
|
|
88172
|
CYTP DX EVAL FNA 1ST EA SITE |
884
|
1,172
|
|
J0330
|
SUCCINYCHOLINE CHLORIDE INJ |
815
|
5,519
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
771
|
1,553
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
720
|
721
|
|
J7120
|
RINGERS LACTATE INFUSION |
713
|
1,078
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D34 related to the following DRG Codes:
011-013
643-645
|
